Citi downgrades Sintex to ‘sell’ , cuts target price to Rs 52
With a sharp overshoot in capex in FY12 and deterioration in working capital, Citigroup thesis has been invalidated and, hence, it has downgraded the stock to ‘Sell’
This has not played out in FY12. With a sharp overshoot in capex in FY12 and deterioration in working capital, Citigroup thesis has been invalidated and, hence, it has downgraded the stock to ‘Sell’ . “We cut our target price to Rs 52 from Rs 104 as we now use 5.3x EV/EBITDA on March 13E to capture the increasing possibility that a large part of FCCBs will have to be funded by interest-bearing debt,” said the Citigroup note.
Citigroup estimates do not yet factor in the replacement of FCCBs with high-cost debt, which may lead to a further downside in numbers. FY12-FY 14E EPS has been cut by 2% to 14% to factor in FY12 results and slowdown in monolithic and custom-molding businesses.
Download ET Markets APP